Article Details

Zacks Investment Research Downgrades Ironwood Pharmaceuticals (NASDAQ:IRWD) to Strong Sell

Retrieved on: 2021-02-22 16:07:30

Tags for this article:

Click the tags to see associated articles and topics

Zacks Investment Research Downgrades Ironwood Pharmaceuticals (NASDAQ:IRWD) to Strong Sell. View article details on hiswai:

Excerpt

Nisa Investment Advisors LLC now owns 6,830 shares of the biotechnology company's stock worth $61,000 after purchasing an additional 5,650 shares ...

Article found on: www.marketbeat.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up